Bakytgul Yermekbayeva

Bakytgul Yermekbayeva

Auto-generated profile, based on publicly available information

Bakytgul Yermekbayeva

National Laboratory Astana, Center for Life Sciences, Nazarbayev University, Astana, Kazakhstan.

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Clinical Therapeutics
Verified
Journal Article
Open access
TNT. Nurgozhin
T. Nurgozhin
AGAlexander Gulyaev
Alexander Gulyaev
SLS. Lokhvytsky
S. Lokhvytsky
BYB. Yermekbayeva
B. Yermekbayeva
SSShynggys Sergazy
Shynggys Sergazy
KBKulzhan Berikkhanova
Kulzhan Berikkhanova

1 January 2025 in Journal of Applied Oral Science
Verified
Journal Article
Open access
AIArgul Issilbayeva
Argul Issilbayeva
JZJarmukhanov Zharkyn
Jarmukhanov Zharkyn
SKSamat Kozhakhmetov
Samat Kozhakhmetov
YBYermekbayeva Bakytgul
Yermekbayeva Bakytgul
LCLaura Chulenbayeva
Laura Chulenbayeva
AZAnara Zhumadilova
Anara Zhumadilova
Objective The oral microbiome is one of the most complex microbial ecosystems in the host. This study aimed to investigate and characterize the oral microbiome composition in Kazakhstani adolescents associated with dental caries. Methodology The study included 312 adolescents, with 241 individuals presenting with caries and 71 caries-free, aged 12-15 years. Dental caries assessment was performed using DMFT (Decayed, missed, filled teeth) index. Oral samples were collected, and 16S rRNA (16S ribosomal ribonucleic acid) gene sequencing targeting the V3-V4 hypervariable regions on an Illumina MiSeq platform was performed to profile the microbial communities. Functional metagenomic predictions were generated using PICRUSt2 v2.5.0, using the KEGG database for bacterial pathway abundance estimation. Data analysis was conducted using Python 3.9.16 and R 4.2.2. Results The alpha diversity was insignificant, while beta diversity analysis demonstrated clear distinctions by Bray-Curtis (F=2.5, p=0.003) and weighted UniFrac distances (F=4.4, p=0.002). The Neisseria and Prevotella genera, and Gammaproteobacteria class showed significant associations with dental caries (MaAsLin2 p≤0.05, LDA≥2), stronger predictive power (AUC=0.65, F1=0.83), and higher predicted functional activity through glutathione metabolism, RNA degradation, and unsaturated fatty acid metabolism pathways. Conclusions This study identified specific oral microbiome patterns associated with dental caries in Kazakhstani adolescents, revealing interactions between key bacterial taxa and metabolic pathways.

1 February 2019
Verified
Journal Article
Closed access
TAT Algazina
T Algazina
BYBakytgul Yermekbayeva
Bakytgul Yermekbayeva
GBG Batpenova
G Batpenova
AKAlmagul Kushugulova
Almagul Kushugulova

20 May 2020 in medRxiv
Verified
Preprint
Open access
PDF file
SYSergey Yegorov
Sergey Yegorov
DBDmitriy D Babenko
Dmitriy D Babenko
SKSamat Kozhakhmetov
Samat Kozhakhmetov
LALyudmila Akhmaltdiniva
Lyudmila Akhmaltdiniva
IKIrina Kadyrova
Irina Kadyrova
AKAlmagul Kushugulova
Almagul Kushugulova
Objective: Psoriasis is a chronic inflammatory condition that predominantly affects the skin and is associated with extracutaneous disorders, such as inflammatory bowel disease and arthritis. Changes in gut immunology and microbiota are important drivers of proinflammatory disorders and could play a role in the pathogenesis of psoriasis. Therefore, we explored whether psoriasis in a Central Asian cohort is associated with alterations in select immunological markers and/or microbiota of the gut. Setting: We assessed correlates of psoriasis in a community from Kazakhstan. Participants: Outpatients, aged 30-45 years, of a dermatology clinic presenting with plaque, guttate or palmoplantar psoriasis (n=20), and age-sex matched subjects without psoriasis (n=20). Design: We undertook a cross-sectional study of stool samples. Stool supernatant was subjected to multiplex ELISA to assess the concentration of 47 cytokines and immunoglobulins and to 16S rRNA gene sequencing to characterize microbial diversity in both psoriasis+ participants and controls. Results: The psoriasis+ group tended to have higher concentrations of most analytes in stool (29/47=61.7%) and gut IL-1α was significantly elevated (4.19-fold, p=0.007) compared to controls. Psoriasis was associated with alterations in gut Firmicutes, including elevated Faecalibacterium and decreased Oscillibacter and Roseburia abundance, but no association was observed between gut microbial diversity or Firmicutes/Bacteroidetes ratios and disease status. Conclusions: Psoriasis may be associated with gut inflammation and dysbiosis. Studies are warranted to explore the use of gut microbiome-focused therapies in the management of psoriasis in this under-studied population.

28 January 2026 in Наука и здравоохранение
Verified
Journal Article
Closed access
AAAkbota Aitkulova
Akbota Aitkulova
TKT.B. Kadenova
T.B. Kadenova
AGAidana Gabdulkayum
Aidana Gabdulkayum
DYDauren Yerezhepov
Dauren Yerezhepov
SRSaule Rakhimova
Saule Rakhimova
DSDos Djurmakhanbet Sarbassov
Dos Djurmakhanbet Sarbassov
Introduction. Circulating tumor DNA (ctDNA) has emerged as a valuable biomarker for non-invasive cancer diagnostics and treatment monitoring. However, pre-analytical variables, including blood collection and sample processing, significantly influence ctDNA yield and analytical reliability. Optimizing these conditions is crucial for ensuring reproducible and accurate ctDNA measurements. Aim. To perform a comparative evaluation of blood collection tubes and DNA extraction methods for the isolation of circulating tumor DNA from the blood plasma of patients with oncological diseases. Materials and Methods. Plasma samples were collected using two types of blood collection tubes: PaxGene and Streck. ctDNA was extracted using three different systems: Raissol, MagMax, and QiaAmp. Quantitative performance, reproducibility, and variability of ctDNA yield were assessed across all combinations of collection tubes and extraction methods. Statistical analysis was performed to evaluate differences among extraction systems. Discussion. The results demonstrated that QiaAmp consistently provided higher ctDNA concentrations across both collection systems. Samples collected in PaxGene tubes exhibited lower variability and improved analytical stability compared with Streck tubes. Statistically significant differences among extraction methods were observed for PaxGene samples, while increased variability in Streck samples limited the ability to discriminate between methods. These findings emphasize the critical role of pre-analytical optimization in ctDNA workflows and support the implementation of standardized protocols to improve reliability in liquid biopsy analysis. Conclusion. The results demonstrate that both blood collection tubes and the DNA extraction method significantly affect ctDNA recovery, highlighting the importance of optimizing and standardizing pre-analytical workflows for reliable liquid biopsy analysis. Введение. Циркулирующая опухолевая ДНК (ctDNA) стала ценным биомаркером для неинвазивной диагностики рака и мониторинга терапии. Однако преданалитические переменные, включая сбор крови и обработку образцов, существенно влияют на выход ctDNA и надежность анализа. Оптимизация этих условий необходима для обеспечения воспроизводимости и точности измерений ctDNA. Цель. Целью данного исследования было проведение сравнительной оценки эффективности пробирок для сбора крови и методов экстракции ДНК при выделении циркулирующей опухолевой ДНК из плазмы крови пациентов с онкологическими заболеваниями. Материалы и методы. Плазменные образцы были собраны с использованием двух типов пробирок: PaxGene и Streck. Экстракция ctDNA проводилась с использованием трех систем: Raissol, MagMax и QiaAmp. Оценивались количественные показатели, воспроизводимость и вариабельность выхода ctDNA для всех комбинаций пробирок и методов экстракции. Для оценки различий между методами экстракции проводился статистический анализ. Обсуждение. Результаты показали, что система QiaAmp стабильно обеспечивала более высокие концентрации ctDNA при использовании обеих пробирок. Образцы, собранные в пробирки PaxGene, продемонстрировали меньшую вариабельность и улучшенную аналитическую стабильность по сравнению с пробирками Streck. Статистически значимые различия между методами экстракции наблюдались для образцов PaxGene, тогда как повышенная вариабельность в образцах Streck ограничивала возможность различия методов. Эти данные подчеркивают критическую роль оптимизации преданалитических условий и поддерживают внедрение стандартизированных протоколов для повышения надежности анализа жидкостной биопсии. Заключение. Полученные результаты показывают, что как тип пробирок для сбора крови, так и используемые методы экстракции ДНК существенно влияют на выход циркулирующей опухолевой ДНК, что подчёркивает необходимость оптимизации и стандартизации преданалитических этапов для надёжного анализа жидкостной биопсии. Кіріспе. Циркуляциялық қатерлі ісік ДНҚ (ctDNA) ракты инвазивті емес диагностикалау және емдеу мониторингі үшін маңызды биомаркерге айналды. Алайда, қан жинау және үлгілерді өңдеу сияқты алдын ала аналитикалық факторлар ctDNA шығымына және...

6 October 2026 in Eurasian Journal of Applied Biotechnology
Verified
Journal Article
Open access
PDF file
BYB.A. Yermekbayeva
B.A. Yermekbayeva
UKUlykbek Kairov
Ulykbek Kairov
DBDinara Begimbetova
Dinara Begimbetova
AKA.M. Kukanova
A.M. Kukanova
AMA.K. Makishev
A.K. Makishev
Background: Addressing the therapeutic challenges associated with Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) mutant cancers remains a significant focus in oncology. The combined intravenous administration of the D-isomer of vitamin C (D-VC) (dextro-rotatory isomer of ascorbic acid) and arsenic trioxide (ATO) is proposed as a potential approach for achieving an anti-tumor effect in Colorectal cancer (CRC) with KRAS-mutant tumor cells. ATO enhances the oxidative effect of vitamin C (VC), and the combination of both drugs provides effective eradication of KRAS-mutant cancer cells. A potent synergistic effect of the VC and ATO combination has been observed about KRAS-mutant cancer cells. Purpose: This clinical trial aims to assess the tolerability and safety of intravenous administration of D-VC along with ATO in patients with advanced/metastatic malignancies who have exhausted standard therapy. Methods and Patients: This single-center Phase I clinical trial evaluated the tolerability and safety of D-VC when administered intravenously alone or in sequential administration with ATO. The target group for the Phase I exploratory clinical trial includes 10 patients with advanced/metastatic malignant neoplasms who have exhausted standard therapy. Results: The administration of the drug followed the treatment regimen according to the ap-proved study protocol. After a single intravenous infusion of D-VC in escalating doses of 0.05 g/kg - 0.1 g/kg - 0.15 g/kg - 0.3 g/kg all patients felt satisfactory, and no subjective intolerance to the investigational drug was reported. The main functional and laboratory parameters remained within normal values recorded at the start of the study. The maximum tolerated dose of D-VC was determined to be 0.3 g/kg, and this dose was chosen as the baseline for the second stage of the study, where D-VC (0.3 g/kg) was administered alongside ATO (0.15 mg/kg). Conclusions: Our findings showed favorable safety and well-tolerated profiles and provided the recommended dose for high-dose D-VC in combination with АТО.